EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

A cross-sectional study of seroprevalence in Armenia, 2025: measles, mumps, rubella, and diphtheria

A Y Popova, V S Smirnov, S A Egorova, S A Atoyan, L V Buts, A M Milichkina, G G Melik-Andreasyan, O B Zhimbaeva, S S Grigoryan, Z G Grigoryan, E M Danilova, E S Ramsay und 11 weitere

Frontiers in Public Health · 02.07.2026 · 14

DOI: 10.3389/fpubh.2026.1861729 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Frontiers in Public Health, online erschienen am 02.07.2026. Verfasst von A Y Popova und 22 weiteren Autor:innen. Beteiligte Einrichtung: Federal Service for the Oversight of Consumer Protection and Welfare, Moscow, Russia. Hauptthemen laut MEDLINE: Measles, Mumps, Rubella, Diphtheria. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prevention and control of vaccine-preventable infections is a key component of maintaining public health, and the overall state of immunity is the determining factor. Objective of the study To study herd immunity of the Armenian population to measles, rubella, mumps, and diphtheria. Materials and methods The study involved 5,513 individuals from all regions aged from 1 year and above. A cohort of volunteers, stratified into 9 age groups, was formed including by region and activity using a web application. For each infection, the presence and/or levels of immunoglobulin G were determined by the enzyme immunoassay method using Russian-made test systems.

Results

The cohort average seroprevalence values for measles, rubella, mumps, and diphtheria were 88.3%, 97.2, 83.2, and 56.3%, respectively. The least protected age groups were: children <5 years (80.7% seropositive) and adults 30–49 years (82–83%) regarding measles; adolescents and adults <49 years (73–79%) regarding mumps; and the older adults (34.4%) regarding diphtheria. Most volunteers had: low or moderate measles Ab levels (0.18–1 IU/mL); high levels of rubella Abs (>200 IU/mL); and a basic protective level of diphtheria toxin Abs (0.1–1 IU/mL). With age, a trend is seen: seropositivity for the viral pathogens (measles, mumps, and rubella) increased to maximum values; and diphtheria seropositivity decreased to minimum values.

Conclusion

The level of herd immunity in Armenia is sufficient only for rubella, as confirmed by the absence of cases. Currently, immunity to measles and mumps is present, which prevents outbreaks but may not be fully preventive of sporadic cases. Despite the absence of diphtheria, insufficient protection in older adults makes them a risk group for incidence and severity. However, immunity levels in our study were assessed based only on humoral immunity, which may underrepresent the full immunological response, including that mediated by cellular immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeaslesMumpsRubellaDiphtheriaHumansSeroepidemiologic StudiesArmeniaAdultFemaleCross-Sectional StudiesMaleMiddle AgedAdolescentChildChild, PreschoolInfantYoung AdultImmunity, HerdImmunoglobulin G

Stichwörter der Autor:innen

Republic of Armeniadiphtheriaherd immunitymeaslesmumpsrubellaseroprevalencevaccination

Substanzen

Immunoglobulin G

Autor:innen und Institutionen

  • Federal Service for the Oversight of Consumer Protection and Welfare, Moscow, Russia.
  • Saint Petersburg Pasteur Institute, St. Petersburg, Russia.
  • National Center for Disease Control, Ministry of Health of the Republic of Armenia, Yerevan, Armenia.
  • National Institute of Health, Ministry of Health of the Republic of Armenia, Yerevan, Armenia.

Zitieren

APA

Popova, A. Y., Smirnov, V. S., Egorova, S. A., Atoyan, S. A., Buts, L. V., Milichkina, A. M., Melik-Andreasyan, G. G., Zhimbaeva, O. B., Grigoryan, S. S., Grigoryan, Z. G., Danilova, E. M., Ramsay, E. S., Drobyshevskaya, V. G., Starkova, D. A., Frolova, K. A., Zotkin, N. N., Arbuzova, T. V., Suzhaeva, L. V., Svarval, A. V., …, & Totolian, A. A. (2026). A cross-sectional study of seroprevalence in Armenia, 2025: measles, mumps, rubella, and diphtheria. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1861729

Vancouver

Popova AY, Smirnov VS, Egorova SA, Atoyan SA, Buts LV, Milichkina AM, et al. A cross-sectional study of seroprevalence in Armenia, 2025: measles, mumps, rubella, and diphtheria. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1861729

BibTeX
@article{Popova2026,
  author = {Popova, A Y and Smirnov, V S and Egorova, S A and Atoyan, S A and Buts, L V and Milichkina, A M and Melik-Andreasyan, G G and Zhimbaeva, O B and Grigoryan, S S and Grigoryan, Z G and Danilova, E M and Ramsay, E S and Drobyshevskaya, V G and Starkova, D A and Frolova, K A and Zotkin, N N and Arbuzova, T V and Suzhaeva, L V and Svarval, A V and Ivanov, V A and Kotsar, O V and Smolensky, V Y and Totolian, A A},
  title = {A cross-sectional study of seroprevalence in Armenia, 2025: measles, mumps, rubella, and diphtheria},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1861729}
}
Kostenlos starten →